tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of David Turkaly, 160 are a BUY (93.57%), 10 are a HOLD (5.85%), 1 are a SELL (0.58%).
Analyst David Turkaly, carries an average stock price target met ratio of 31.9% that have a potential upside of 31.51% achieved within 231 days. Previously, David Turkaly worked at JMP.
David Turkaly’s has documented 327 price targets and ratings displayed on 22 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on AXGN, Axogen at 30-Oct-2025.
Analyst best performing recommendations are on STIM (NEURONETICS).
The best stock recommendation documented was for STIM (NEURONETICS) at 8/14/2024. The price target of $3 was fulfilled within 167 days with a profit of $2.17 (261.45%) receiving and performance score of 15.66.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold
1 years 1 months 17 days ago
(16-Sep-2024)
3/3 (100%)
$1.8 (21.95%)
243
Buy
$4.5
$1.47 (48.51%)
$3
2 years 2 months 22 days ago
(11-Aug-2023)
14/16 (87.5%)
$-0.55 (-10.89%)
297
Buy
$9
$5.97 (197.03%)
$6
2 years 4 months 18 days ago
(15-Jun-2023)
2/3 (66.67%)
$2.05 (29.50%)
81
Buy
$17
$13.97 (461.06%)
$12
3 years 3 months 14 days ago
(19-Jul-2022)
0/2 (0%)
$8.43 (98.37%)
Which stock is David Turkaly is most bullish on?
Which stock is David Turkaly is most reserved on?
What Year was the first public recommendation made by David Turkaly?
